Physician

Margit Lai Wun Juhasz, M.D.

According to 2025 Medicare claims, Margit Juhasz, M.D. (NPI: 1225488208) practices dermatology in the Seattle-Bellevue-Kent, WA market, with the plurality of this provider's patient population coming from King, WA. This provider's primary affiliated billing organization is AESTHETIC & GENERAL DERMATOLOGY OF SEATTLE (NPI: 1518962935; TIN: 911886576) and primary practice location at 98168-3404.

Juhasz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 505 traditional Medicare patients, billed 2,579 HCPCS/CPT codes, and received $436,021 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 257 prescription claims across 145 beneficiaries totaling $4,547 in drug costs, led by Metronidazole (Metronidazole). Open Payments data shows 10 records totaling $217. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have fallen sharply in recent years, from $3,439 to $4,547. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$218K$436K2023 Medicare payment: $133,313 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $436,021 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023185716$133,313
20245052,579$436,021

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$32K$63K2019 Drug cost: $3,439 (USD; Tot_Drug_Cst)2021 Drug cost: $61,630 (USD; Tot_Drug_Cst)2022 Drug cost: $63,028 (USD; Tot_Drug_Cst)2023 Drug cost: $1,715 (USD; Tot_Drug_Cst)2024 Drug cost: $4,547 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R22$3,439
2020N/RN/RN/R
2021N/R14$61,630
20224552$63,028
202397138$1,715
2024145257$4,547

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks194235$511
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks113177$348
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more137160$59
11102Biopsy of related skin growth, first growth115129$56
17000Destruction of precancer skin growth, 1 growth130140$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MetronidazoleMetronidazole12372$1,057
Clobetasol PropionateClobetasol Propionate19517$759
KetoconazoleKetoconazole451,249$656
MupirocinMupirocin34866$305
Doxycycline MonohydrateDoxycycline Monohydrate11192$182

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$217Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Margit Lai Wun Juhasz, M.D.?

Tedicare shows public-source Medicare data for Margit Lai Wun Juhasz, M.D. (NPI 1225488208), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Margit Lai Wun Juhasz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Margit Lai Wun Juhasz, M.D.?

Margit Lai Wun Juhasz, M.D. is linked to AESTHETIC & GENERAL DERMATOLOGY OF SEATTLE (billing NPI 1518962935) in the available physician profile data.

Does Margit Lai Wun Juhasz, M.D. have Open Payments data?

Margit Lai Wun Juhasz, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.